Literature DB >> 24530102

Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study.

Hiroshi Ogura1, Satoshi Gando2, Daizoh Saitoh3, Naoshi Takeyama4, Shigeki Kushimoto5, Seitaro Fujishima6, Toshihiko Mayumi7, Tsunetoshi Araki8, Hiroto Ikeda9, Joji Kotani10, Yasuo Miki11, Shin-Ichiro Shiraishi12, Koichiro Suzuki13, Yasushi Suzuki14, Kiyotsugu Takuma15, Ryosuke Tsuruta16, Yoshihiro Yamaguchi17, Norio Yamashita18, Naoki Aikawa6.   

Abstract

Severe sepsis is a leading cause of morbidity and mortality in the intensive care unit (ICU). We conducted a prospective multicenter study to evaluate epidemiology and outcome of severe sepsis in Japanese ICUs. The patients were registered at 15 general critical care centers in Japanese tertiary care hospitals when diagnosed as having severe sepsis. Of 14,417 patients, 624 (4.3%) were diagnosed with severe sepsis. Demographic and clinical characteristics at enrollment (Day 1), physiologic and blood variables on Days 1 and 4, and mortality were evaluated. Mean age was 69.0 years, and initial mean Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores were 23.4 and 8.6, respectively. The 28-day mortality was 23.1%, and overall hospital mortality was 29.5%. SOFA score and disseminated intravascular coagulation (DIC) score were consistently higher in nonsurvivors than survivors on Days 1 and 4. SOFA score, DIC score on Days 1 and 4, and hospital mortality were higher in patients with than without septic shock. SOFA score on Days 1 and 4 and hospital mortality were higher in patients with than without DIC. Logistic regression analyses showed age, presence of septic shock, DIC, and cardiovascular dysfunction at enrollment to be predictors of 28-day mortality and presence of comorbidity to be an additional predictor of hospital mortality. Presence of septic shock or DIC resulted in approximately twice the mortality of patients without each factor, whereas the presence of comorbidity may be a significant predictor of delayed mortality in severe sepsis.
Copyright © 2013 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DIC; Epidemiology; Japan; Outcome; Septic shock; Severe sepsis

Mesh:

Year:  2013        PMID: 24530102     DOI: 10.1016/j.jiac.2013.07.006

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  36 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

Review 2.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Manu Shankar-Hari; Gary S Phillips; Mitchell L Levy; Christopher W Seymour; Vincent X Liu; Clifford S Deutschman; Derek C Angus; Gordon D Rubenfeld; Mervyn Singer
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Sepsis in Buraidah Central Hospital, Qassim, Kingdom of Saudi Arabia.

Authors:  Gasim I Gasim; Imad R Musa; Taha Yassin; Hani A Al Shobaili; Ishag Adam
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

4.  Impact of serum glucose levels on disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis.

Authors:  Shigeki Kushimoto; Satoshi Gando; Daizoh Saitoh; Toshihiko Mayumi; Hiroshi Ogura; Seitaro Fujishima; Tsunetoshi Araki; Hiroto Ikeda; Joji Kotani; Yasuo Miki; Shin-Ichiro Shiraishi; Koichiro Suzuki; Yasushi Suzuki; Naoshi Takeyama; Kiyotsugu Takuma; Ryosuke Tsuruta; Yoshihiro Yamaguchi; Norio Yamashita; Naoki Aikawa
Journal:  Acute Med Surg       Date:  2014-08-14

5.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  Acute Med Surg       Date:  2018-02-05

6.  A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC.

Authors:  Toshiaki Iba; Marcello Di Nisio; Jecko Thachil; Hideo Wada; Hidesaku Asakura; Koichi Sato; Daizoh Saitoh
Journal:  Clin Appl Thromb Hemost       Date:  2017-07-27       Impact factor: 2.389

7.  Suppression of Staphylococcus aureus Superantigen-Independent Interferon Gamma Response by a Probiotic Polysaccharide.

Authors:  Wonbeom Paik; Francis Alonzo; Katherine L Knight
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

8.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  J Intensive Care       Date:  2018-02-02

9.  The Outcome of Sepsis Patients Admitted to the Intensive Care Unit: Experience of 100 Cases.

Authors:  Alaa Abood Najim Al-Wadees; Ali Najeh Al-Khayyat; Qusay Abdulazahraa Yaqoob
Journal:  Med Arch       Date:  2021-02

10.  Evaluation of Antibiotic Use Among Sepsis Patients in an Intensive Care Unit: A cross-sectional study at a referral hospital in Indonesia.

Authors:  Ratna S Dewi; Maksum Radji; Rizka Andalusia
Journal:  Sultan Qaboos Univ Med J       Date:  2018-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.